Journal of Natural Products · 2014 · 46 citations · 10 references
Life SciencesBiochemistryMicrobiologyAntimicrobial ResistanceDrug DiscoverySynthetic Medicinal ChemistryAntibiotic ProductionAntibiotic ResistanceAntimicrobial PeptidesMarine Natural ProductsAntibiotic DiscoveryAntimicrobial Peptide ActivityAntimicrobial Peptide ProductionDrug-resistant PathogensMarine Microbial Natural ProductsMultidrug-resistant PathogensPeptide Structure-activity RelationshipsRibosomally Synthesized Peptide Biosynthesis
NAI-107, a lantibiotic produced by Microbispora sp. 107891, shows potent activity against multi-drug-resistant bacterial pathogens. It is produced as a complex of related molecules, which is unusual for ribosomally synthesized peptides. Here we describe the identification, characterization, and antibacterial activity of the congeners produced by Microbispora sp. 107891 and by the related Microbispora corallina NRRL 30420. These molecules differ by the presence of two, one, or zero hydroxyl groups at Pro-14, by the presence of a chlorine at Trp-4, and/or by the presence of a sulfoxide on the thioether of the first lanthionine.
10
Constance M. Harris, Kannan Rajamoorthi, Hana Kopecka et al. · Journal of the American Chemical Society · 1985 · 158 citations